Iotrolan for system suitability

Get a Price/Quote

MOQ : 1 Kilograms

Iotrolan for system suitability Specification

Molecular Weight
1626.2 Grams (g)

Purity
98%

Melting Point
−115 C (−175 F; 158 K)

Usage
Iotrolan (trade name Isovist) is a radiocontrast agent, a substance used to improve the visibility of body structures on images obtained by X-ray techniques. It is particularly used to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.

Molecular Formula
C37H48I6N6O18

Iotrolan for system suitability Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Central America, Africa, Middle East, South America, Western Europe, Australia, Asia, Eastern Europe, North America

Main Domestic Market
All India

About Iotrolan for system suitability

Iotrolan for system suitabilityEuropean Pharmacopoeia (EP) Reference StandardSynonym: IotrolanCAS Number79770-24-4Empirical Formula (Hill Notation)C37H48I6N6O18Molecular Weight1626.23PropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,EP Standards,EP Standards I - K,Pharmacopeia & Metrological Institutes Standardsform neatformat neatstorage temp. 2-8C

FAQs of Iotrolan for system suitability:

Q: What is the molecular formula of Iotrolan?

A: The molecular formula of Iotrolan is C37H48I6N6O18.

Q: What is the molecular weight of Iotrolan?

A: The molecular weight of Iotrolan is 1626.2 grams (g).

Q: What is the purity of Iotrolan?

A: The purity of Iotrolan is 98%.

Q: What is the usage of Iotrolan?

A: Iotrolan (trade name Isovist) is a radiocontrast agent used to improve the visibility of body structures on X-ray images. It is particularly utilized to image spaces surrounding the central nervous system, such as the ventricles, after injection into the cerebrospinal fluid.